Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
- Status
- COMPLETED
- Phase
- PHASE1
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Preoperative Treatment With Cetuximab and/or IMC-A12
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab
- Status
- COMPLETED
- Phase
- PHASE1
Sirolimus and Cetuximab in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
- Status
- COMPLETED
- Phase
- PHASE2
Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016)
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE1